Alvotech (NASDAQ:ALVO) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On December 31, ...

The central focus of the inquiry revolves around whether Alvotech provided adequate transparency to the market concerning the status of its Biologics License Application (BLA) for AVT05—a critical ...

Alvotech (ALVO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.05. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for ...

Fintel reports that on September 23, 2025, Deutsche Bank upgraded their outlook for Alvotech (NasdaqGM:ALVO) from Hold to Buy. As of September 14, 2025, the average one-year price target for Alvotech ...

The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Alvotech ("Alvotech" or the "Company") (NASDAQ:ALVO) investors concerning the Company's and/or members of its ...

Alvotech (NASDAQ:ALVO) is one of the Stocks That Could Mint Millionaires in 2026. The firm recently launched a $100 million offering of senior unsecured convertible notes due 2030 and reaffirmed its ...

Photo of Lisa Graver Lisa Graver, Incoming CEO of Alvotech Róbert Wessman to continue serving as Executive Chairman in ...

Alvotech (NASDAQ:ALVO) is set to give its latest quarterly earnings report on Wednesday, 2025-11-12. Here's what investors need to know before the announcement. Analysts estimate that Alvotech will ...